Advanced search
Publication Cover
Journal of Inflammation Research Volume 14, 2021 - Issue
Submit an article Journal homepage
161
Views
35
CrossRef citations to date
0
Altmetric
Review

The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic

Nandeeta Samad1 Department of Public Health, North South University, Dhaka, 1229, Bangladesh
,
Temitayo Eniola Sodunke2 Department of Anatomy, University of Ilorin, Ilorin, Kwara State, Nigeria
,
Abdullahi Rabiu Abubakar3 Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, 700233, Nigeria
,
Iffat Jahan4 Department of Physiology, Eastern Medical College, Cumilla, Bangladesh
,
Paras Sharma5 Department of Pharmacognosy, BVM College of Pharmacy, Gwalior, India
,
Salequl Islam6 Department of Microbiology, Jahangirnagar University, Dhaka, 1342, Bangladesh
,
Siddhartha Dutta7 Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
&
Mainul Haque8 The Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, MalaysiaCorrespondence[email protected]
 show all
Pages 527-550 | Published online: 26 Feb 2021

References

  • She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020;9(1):19. doi:10.1186/s40169-020-00271-z
  • Liu YC, Kuo RL, Shih SR. COVID-19: the first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328–333. doi:10.1016/j.bj.2020.04.007
  • World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum; 2020. Available from: https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum. Accessed October 30, 2020.
  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi:10.1038/s41586-020-2008-3
  • Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49(3):717–726. doi:10.1093/ije/dyaa033
  • World Health Organization. WHO director-general’s opening remarks at the mission briefing on COVID-19-12 March 2020; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---12-march-2020. Accessed October 30, 2020.
  • Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis, and potential therapeutics). New Microbes New Infect. 2020;35:100679. doi:10.1016/j.nmni.2020.100679
  • Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. doi:10.1038/s41564-020-0695-z.
  • Wu Y, Ho W, Huang Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020;395(10228):949–950. doi:10.1016/S0140-6736(20)30557-2
  • World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Data last updated: 2020/12/1, 4:28 pm CET Overview Data Table; 2020. Available from: https://covid19.who.int/?gclid=CjwKCAjw8-78BRA0EiwAFUw8LAR8elp5pjv_gRFZLrIsKzI5yfkTmkVAEC0La7MjyOzHWfdL2E-gKRoC6kIQAvD_BwE. Accessed January 19, 2021.
  • Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76(1):105–115. doi:10.1353/bhm.2002.0022
  • Erkoreka A. The Spanish influenza pandemic in occidental Europe (1918–1920) and victim age. Influenza Other Respir Viruses. 2010;4(2):81–89. doi:10.1111/j.1750-2659.2009.00125.x
  • Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, Valleron AJ. Mortality burden of the 1918–1919 influenza pandemic in Europe. Influenza Other Respir Viruses. 2009;3(3):99–106. doi:10.1111/j.1750-2659.2009.00080.x
  • Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Crit Care. 2019;23(1):337. doi:10.1186/s13054-019-2616-1
  • Sutton TC. The pandemic threat of emerging H5 and H7 Avian influenza viruses. Viruses. 2018;10(9):461. doi:10.3390/v10090461
  • Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53–60. doi:10.1086/515616
  • Turbelin C, Souty C, Pelat C, et al. Age distribution of influenza-like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One. 2013;8(6):e65919. doi:10.1371/journal.pone.0065919
  • Buchholz U, Buda S, Reuß A, Haas W, Uphoff H. Todesfälle durch Influenzapandemien in Deutschland 1918 bis 2009. Schätzwerte auf Basis der Literatur und ergänzende eigene Berechnungen [Influenza pandemic deaths in Germany from 1918 to 2009. Estimates based on literature and own calculations]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59(4):523–536. German. PMID: 26984565.. doi:10.1007/s00103-016-2324-9.
  • Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global mortality impact of the 1957–1959 influenza pandemic. J Infect Dis. 2016;213(5):738–745. doi:10.1093/infdis/jiv534
  • Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One. 2012;7(9):e45051. doi:10.1371/journal.pone.0045051
  • Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modeling study. Lancet Infect Dis. 2012;12(9):687–695. doi:10.1016/S1473-3099(12)70121-4
  • Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med. 2010;38(4 Suppl):e10–e20. doi:10.1097/CCM.0b013e3181ceb25b
  • Andreasen V, Viboud C, Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis. 2008;197(2):270–278. doi:10.1086/524065
  • Taubenberger JK. The origin and virulence of the 1918 “Spanish” influenza virus. Proc Am Philos Soc. 2006;150(1):86–112.
  • Patterson KD, Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bull Hist Med. 1991;65(1):4–21.
  • Taubenberger JK. The virulence of the 1918 pandemic influenza virus: unraveling the enigma. Arch Virol Suppl. 2005;19:101–115. doi:10.1007/3-211-29981-5_9
  • Burnet FM, Clark E. Influenza: A Survey of the Last 50 Years in the Light of Modern Work on the Virus of Epidemic Influenza. Melbourne: Macmillan and Company, Limited; 1942.
  • Frost WH. Statistics of influenza morbidity: with special reference to certain factors in case incidence and case fatality. Public Health Rep. 1920;35(11):584–597. doi:10.2307/4575511
  • Franco-Paredes C, Hernandez-Ramos I, Del Rio C, Alexander KT, Tapia-Conyer R, Santos-Preciado JI. H1N1 influenza pandemics: comparing the events of 2009 in Mexico with those of 1976 and 1918–1919. Arch Med Res. 2009;40(8):669–672. doi:10.1016/j.arcmed.2009.10.004
  • Marks G, Beatty WK. Epidemics. 1st ed. New York: Charles Scribner’s Sons; 1976.
  • Wallace R, Kohatsu N. Maxcy-Rosenau-Last Public Health & Preventive Medicine. 15th ed. New York: McGraw-Hill Medical; 2008.
  • Noymer A, Garenne M. The 1918 influenza epidemic’s effects on sex differentials in mortality in the United States. Popul Dev Rev. 2000;26(3):565–581. doi:10.1111/j.1728-4457.2000.00565.x
  • Billings M The influenza pandemic of 1918. First Published 1997; 2005. Available from: https://virus.stanford.edu/uda/#:~:text=The%20death%20rate%20for%2015,street%20and%20died%20rapid%20deaths. Accessed October 31, 2020.
  • Crosby A. America’s Forgotten Pandemic. Cambridge, UK: Cambridge University Press; 1989.
  • Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proc Natl Acad Sci USA. 1999;96(4):1651–1656. doi:10.1073/pnas.96.4.1651
  • Craig R Why Did the 1918 Flu Kill So Many Otherwise Healthy Young Adults? Uncovering a World War, I veteran’s story provided a genealogist and pharmacologist with some clues. The Conservation. The Next Pandemic. Johns Hopkins Blomberg School of Public Health and Smithsonian, National Museum of Natural History; 2017. Available from: https://www.smithsonianmag.com/history/why-did-1918-flu-kill-so-many-otherwise-healthy-young-adults-180967178/. Accessed November 3, 2020.
  • Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962–970. doi:10.1086/591708
  • Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499–522. doi:10.1146/annurev.pathmechdis.3.121806.154316
  • Hsieh YC, Wu TZ, Liu DP, et al. Influenza pandemics: past, present, and future. J Formos Med Assoc. 2006;105(1):1–6. doi:10.1016/S0929-6646(09)60102-9
  • Metersky ML, Masterton RG, Lode H, File TM Jr, Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16(5):e321–31. doi:10.1016/j.ijid.2012.01.003
  • LeCount ER. The pathologic anatomy of influenzal bronchopneumonia. JAMA. 1919;72:650–652. doi:10.1001/jama.1919.02610090034009
  • Winternitz MC, Wason IM, McNamara FP. The Pathology of Influenza. New Haven: Yale University Press; 1920.
  • Wolbach SB. Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass. Johns Hopkins Hosp Bull. 1919;30:104.
  • Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1):72–79. doi:10.1164/rccm.200909-1420OC
  • Gilbert CR, Vipul K, Baram M. Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage. Respir Care. 2010;55(5):623–625.
  • Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep. 2010;125(Suppl 3):16–26. doi:10.1177/00333549101250S305
  • Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical, and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci. 2001;356(1416):1829–1839. doi:10.1098/rstb.2001.1020
  • Rivera-Perez JI, Santiago-Rodriguez TM, Toranzos GA. Paleomicrobiology: a snapshot of ancient microbes and approaches to forensic microbiology. Microbiol Spectr. 2016;4(4). doi:10.1128/microbiolspec.EMF-0006-2015
  • Raoult D, Aboudharam G, Crubézy E, Larrouy G, Ludes B, Drancourt M. Molecular identification by “suicide PCR” of Yersinia pestis as the agent of medieval black death. Proc Natl Acad Sci USA. 2000;97(23):12800–12803. doi:10.1073/pnas.220225197
  • Rafi A, Spigelman M, Stanford J, Lemma E, Donoghue H, Zias J. Mycobacterium leprae DNA from ancient bone detected by PCR. Lancet. 1994;343(8909):1360–1361. doi:10.1016/S0140-6736(94)92494-5
  • Kolman CJ, Centurion-Lara A, Lukehart SA, Owsley DW, Tuross N. Identification of Treponema pallidum subspecies pallidum in a 200-year-old skeletal specimen. J Infect Dis. 1999;180(6):2060–2063. doi:10.1086/315151
  • Drancourt M, Aboudharam G, Signoli M, Dutour O, Raoult D. Detection of 400-year-old Yersinia pestis DNA in human dental pulp: an approach to the diagnosis of ancient septicemia. Proc Natl Acad Sci USA. 1998;95(21):12637–12640. doi:10.1073/pnas.95.21.12637
  • Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science. 1997;275(5307):1793–1796. doi:10.1126/science.275.5307.1793
  • Lina B. History of influenza pandemics. Paleomicrobiology. 2008;199–211. doi:10.1007/978-3-540-75855-6_12
  • Basler CF, Reid AH, Dybing JK, et al. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci USA. 2001;98(5):2746–2751. doi:10.1073/pnas.031575198
  • Xiao YL, Kash JC, Beres SB, Sheng ZM, Musser JM, Taubenberger JK. High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic. J Pathol. 2013;229(4):535–545. doi:10.1002/path.4145
  • Reid AH, Fanning TG, Janczewski TA, Taubenberger JK. Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proc Natl Acad Sci USA. 2000;97(12):6785–6790. doi:10.1073/pnas.100140097
  • Denison AM, Blau DM, Jost HA, et al. Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases. J Mol Diagn. 2011;13(2):123–128. doi:10.1016/j.jmoldx.2010.09.004
  • Impellizzeri FM, Bizzini M. Systematic review and meta-analysis: a primer. Int J Sports Phys Ther. 2012;7(5):493–503.
  • Ahn E, Kang H. Introduction to systematic review and meta-analysis. Korean J Anesthesiol. 2018;71(2):103–112. doi:10.4097/kjae.2018.71.2.103
  • Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409–1417. doi:10.1007/s00296-011-1999-3
  • Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. doi:10.1186/s41073-019-0064-8
  • Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987;106(3):485–488. doi:10.7326/0003-4819-106-3-485
  • McAlister FA, Clark HD, van Walraven C, et al. The medical review article revisited: has the science improved? Ann Intern Med. 1999;131(12):947–951. doi:10.7326/0003-4819-131-12-199912210-00007
  • Roohani N, Hurrell R, Kelishadi R, Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci. 2013;18(2):144–157.
  • Prasad AS. Clinical, immunological, anti-inflammatory, and antioxidant roles of zinc. Exp Gerontol. 2008;43(5):370–377. doi:10.1016/j.exger.2007.10.013
  • Prasad AS, Miale A Jr, Farid Z, Sandstead HH, Schulert AR. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med. 1963;61:537–549.
  • Raulin J. [Chemical studies on vegetation.]. Ann Sci Nat. 1869;11:93–99. French.
  • Sommer AL, Lipman CB. Evidence on the indispensable nature of zinc and boron for higher green plants. Plant Physiol. 1926;1(3):231–249. doi:10.1104/pp.1.3.231
  • Todd WR, Elvehjem CA, Hart EB. Zinc in the nutrition of the rat. Am J Physiol. 1934;107:146–156. doi:10.1152/ajplegacy.1933.107.1.146
  • Blamberg DL, Blackwood UB, Supplee WC, Combs GF. Effect of zinc deficiency in hens on hatchability and embryonic development. Proc Soc Exp Biol Med. 1960;104:217–220. doi:10.3181/00379727-104-25784
  • O’dell BL, Newberne PM, Savage JE. Significance of dietary zinc for the growing chicken. J Nutr. 1958;65(4):503–518. doi:10.1093/jn/65.4.503
  • Tucker HF, Salmon WD. Parakeratosis or zinc deficiency disease in the pig. Proc Soc Exp Biol Med. 1955;88(4):613–616. doi:10.3181/00379727-88-21670
  • Prasad AS, Sandstead HH, Schulert AR, El-Rooby AS. Urinary excretion of zinc in patients with the syndrome of anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med. 1963;62:591–599.
  • Moynahan EJ. Letter: acrodermatitis enteropathica: a lethal, inherited human zinc-deficiency disorder. Lancet. 1974;2(7877):399–400. doi:10.1016/s0140-6736(74)91772-3
  • Barnes PM, Moynahan EJ. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerances treated with synthetic diet. Proc R Soc Med. 1973;66(4):327–329.
  • Hambidge KM, Walravens PA. Disorders of mineral metabolism. Clin Gastroenterol. 1982;11(1):87–117.
  • Sandstead HH. Zinc deficiency. A public health problem? Am J Dis Child. 1991;145(8):853–859. doi:10.1001/archpedi.1991.02160080029016
  • Black MM. Zinc deficiency and child development. Am J Clin Nutr. 1998;68(2Suppl):464S–469S. doi:10.1093/ajcn/68.2.464S
  • Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2002;75(6):1062–1071. doi:10.1093/ajcn/75.6.1062
  • Sharma A, Patni B, Shankhdhar D, Shankhdhar SC. Zinc - an indispensable micronutrient. Physiol Mol Biol Plants. 2013;19(1):11–20. doi:10.1007/s12298-012-0139-1
  • Bhattacharya PT, Misra SR, Hussain M. Nutritional aspects of essential trace elements in oral health and disease: an extensive review. Scientifica (Cairo). 2016;2016:5464373. doi:10.1155/2016/5464373
  • Hojyo S, Fukada T. Roles of zinc signaling in the immune system. J Immunol Res. 2016;2016:6762343. doi:10.1155/2016/6762343
  • Gammoh NZ, Rink L. Zinc in infection and inflammation. Nutrients. 2017;9(6):624. doi:10.3390/nu9060624
  • Jarosz M, Olbert M, Wyszogrodzka G, Młyniec K, Librowski T. Antioxidant and anti-inflammatory effects of Zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology. 2017;25(1):11–24. doi:10.1007/s10787-017-0309-4
  • McCall KA, Huang C, Fierke CA. Function and mechanism of zinc metalloenzymes. J Nutr. 2000;130(5SSuppl):1437S–46S. doi:10.1093/jn/130.5.1437S
  • Robinson PK. Enzymes: principles and biotechnological applications. Essays Biochem. 2015;59:1–41. doi:10.1042/bse0590001
  • Alker W, Haase H. Zinc, and sepsis. Nutrients. 2018;10(8):976. doi:10.3390/nu10080976
  • Cousins RJ, Aydemir TB, Lichten LA. Plenary lecture 2: transcription factors, regulatory elements, and nutrient-gene communication. Proc Nutr Soc. 2010;69(1):91–94. doi:10.1017/S0029665109991790
  • Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi:10.1038/sigtrans.2017.23
  • DeDiego ML, Nieto-Torres JL, Regla-Nava JA, et al. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol. 2014;88(2):913–924. doi:10.1128/JVI.02576-13
  • Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007;35(10):2408–2416. doi:10.1097/01.ccm.0000282072.56245.91
  • Li X, Su J, Cui X, Li Y, Barochia A, Eichacker PQ. Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate. Expert Opin Investig Drugs. 2009;18(8):1047–1060. doi:10.1517/13543780903018880
  • Arnalich F, Garcia-Palomero E, López J, et al. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun. 2000;68(4):1942–1945. doi:10.1128/iai.68.4.1942-1945.2000
  • Younus H. Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim). 2018;12(3):88–93.
  • Marreiro DD, Cruz KJ, Morais JB, Beserra JB, Severo JS, de Oliveira AR. Zinc and oxidative stress: current mechanisms. Antioxidants (Basel). 2017;6(2):24. doi:10.3390/antiox6020024
  • Cruz KJ, de Oliveira AR, Marreiro Ddo N. Antioxidant role of zinc in diabetes mellitus. World J Diabetes. 2015;6(2):333–337. doi:10.4239/wjd.v6.i2.333
  • Oteiza PI, Clegg MS, Zago MP, Keen CL. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med. 2000;28(7):1091–1099. doi:10.1016/s0891-5849(00)00200-8
  • Oteiza PI. Zinc and the modulation of redox homeostasis. Free Radic Biol Med. 2012;53(9):1748–1759. doi:10.1016/j.freeradbiomed.2012.08.568
  • Lee SR. Critical role of zinc as either an antioxidant or a prooxidant in cellular systems. Oxid Med Cell Longev. 2018;2018:9156285. doi:10.1155/2018/9156285
  • Maret W. Zinc and sulfur: a critical biological partnership. Biochemistry. 2004;43(12):3301–3309. doi:10.1021/bi036340p
  • Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr. 2013;4(2):176–190. doi:10.3945/an.112.003210
  • Prasad AS. Impact of the discovery of human zinc deficiency on health. J Trace Elem Med Biol. 2014;28(4):357–363. doi:10.1016/j.jtemb.2014.09.002
  • Prasad AS. Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol. 2012;26(2–3):66–69. doi:10.1016/j.jtemb.2012.04.004
  • Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr. 2019;10(4):696–710. doi:10.1093/advances/nmz013
  • Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: a review. Diabetes Metab Syndr. 2020;14(4):367–382. doi:10.1016/j.dsx.2020.04.015
  • Iovino L, Mazziotta F, Carulli G, et al. High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation. Leuk Res. 2018;70:20–24. doi:10.1016/j.leukres.2018.04.016
  • Albers R, Bourdet-Sicard R, Braun D, et al. Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr. 2013;110(Suppl 2):S1–S30. doi:10.1017/S0007114513001505
  • Rao G, Rowland K. PURLs: zinc for the common cold–not if, but when. J Fam Pract. 2011;60(11):669–671.
  • Basnet S, Mathisen M, Strand TA. Oral zinc and common childhood infections–An update. J Trace Elem Med Biol. 2015;31:163–166. doi:10.1016/j.jtemb.2014.05.006
  • Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today’s battle against COVID-19? Med Hypotheses. 2020;142:109815. doi:10.1016/j.mehy.2020.109815
  • Skalny AV, Rink L, Ajsuvakova OP, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (Review). Int J Mol Med. 2020;46(1):17–26. doi:10.3892/ijmm.2020.4575
  • Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. 2020;323(19):1912–1914. doi:10.1001/jama.2020.5317
  • Yang F, Zhang Y, Tariq A, et al. Food as medicine: a possible preventive measure against coronavirus disease (COVID-19). Phytother Res. 2020;34(12):3124–3136. doi:10.1002/ptr.6770
  • Rerksuppaphol S, Rerksuppaphol L. A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children. Pediatr Rep. 2019;11(2):7954. doi:10.4081/pr.2019.7954
  • Linko R, Karlsson S, Pettilä V, et al. Serum zinc in critically ill adult patients with acute respiratory failure. Acta Anaesthesiol Scand. 2011;55(5):615–621. doi:10.1111/j.1399-6576.2011.02425.x
  • Hemilä H, Haukka J, Alho M, Vahtera J, Kivimäki M. Zinc acetate lozenges for the treatment of the common cold: a randomized controlled trial. BMJ Open. 2020;10(1):e031662. doi:10.1136/bmjopen-2019-031662
  • Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda Á. A hypothesis for the possible role of zinc in the immunological pathways related to COVID-19 infection. Front Immunol. 2020;11:1736. doi:10.3389/fimmu.2020.01736
  • Lyu J, Miao T, Dong J, Cao R, Li Y, Chen Q. Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection? Med Hypotheses. 2020;143:109842. doi:10.1016/j.mehy.2020.109842
  • Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53(3):371–372. doi:10.1016/j.jmii.2020.02.011
  • Wessels I, Rolles B, Rink L. The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol. 2020;11:1712. doi:10.3389/fimmu.2020.01712
  • Hemilä H, Fitzgerald JT, Petrus EJ, Prasad A. Zinc acetate lozenges may improve the recovery rate of common cold patients: an individual patient data meta-analysis. Open Forum Infect Dis. 2017;4(2):ofx059. doi:10.1093/ofid/ofx059
  • Razzaque MS. COVID-19 pandemic: can maintaining optimal zinc balance enhance host resistance? Tohoku J Exp Med. 2020;251(3):175–181. doi:10.1620/tjem.251.175
  • Heller RA, Sun Q, Hackler J, et al. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol. 2020;38:101764. doi:10.1016/j.redox.2020.101764
  • Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479–490. doi:10.1002/jmv.25707
  • Kumar A, Kubota Y, Chernov M, Kasuya H. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med Hypotheses. 2020;144:109848. doi:10.1016/j.mehy.2020.109848
  • Darma A, Ranuh RG, Merbawani W, et al. Zinc supplementation effect on the bronchial cilia length, the number of cilia, and the number of intact bronchial cell in zinc deficiency rats. Indones Biomed J. 2020;12(1):78–84. doi:10.18585/inabj.v12i1.998
  • Truong-Tran AQ, Carter J, Ruffin R, Zalewski PD. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol. 2001;79(2):170–177. doi:10.1046/j.1440-1711.2001.00986.x
  • Roscioli E, Jersmann HP, Lester S, et al. Zinc deficiency as a codeterminant for airway epithelial barrier dysfunction in an ex vivo model of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:3503–3510. doi:10.2147/COPD.S149589
  • Te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro, and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. doi:10.1371/journal.ppat.1001176
  • Rosenkranz E, Metz CH, Maywald M, et al. Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures. Mol Nutr Food Res. 2016;60(3):661–671. doi:10.1002/mnfr.201500524
  • Berg K, Bolt G, Andersen H, Owen TC. Zinc potentiates the antiviral action of human IFN-alpha tenfold. J Interferon Cytokine Res. 2001;21(7):471–474. doi:10.1089/10799900152434330
  • Lin FC, Young HA. Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 2014;25(4):369–376. doi:10.1016/j.cytogfr.2014.07.015
  • Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment? Pan Afr Med J. 2020;35(Suppl2):12. doi:10.11604/pamj.2020.35.2.22877
  • Lang CJ, Hansen M, Roscioli E, et al. Dietary zinc mediates inflammation and protects against wasting and metabolic derangement caused by sustained cigarette smoke exposure in mice. Biometals. 2011;24(1):23–39. doi:10.1007/s10534-010-9370-9
  • Wessels I, Haase H, Engelhardt G, Rink L, Uciechowski P. Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms. J Nutr Biochem. 2013;24(1):289–297. doi:10.1016/j.jnutbio.2012.06.007
  • Jeon KI, Jeong JY, Jue DM. Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J Immunol. 2000;164(11):5981–5989. doi:10.4049/jimmunol.164.11.5981
  • Prasad AS, Bao B, Beck FW, Sarkar FH. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB. Nutrition. 2011;27(7–8):816–823. doi:10.1016/j.nut.2010.08.010
  • Wellinghausen N, Martin M, Rink L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur J Immunol. 1997;27(10):2529–2535. doi:10.1002/eji.1830271010
  • Shittu MO, Afolami OI. Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials. Infez Med. 2020;28(2):192–197. doi:10.3389/fimmu.2019.02347
  • Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-0
  • Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding WQ. Chloroquine is a zinc ionophore. PLoS One. 2014;9(10):e109180. doi:10.1371/journal.pone.0109180
  • Guastalegname M, Vallone A. Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment? Clin Infect Dis. 2020;71(15):888–889. doi:10.1093/cid/ciaa321
  • Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients. 2017;9(12):1286. doi:10.3390/nu9121286
  • Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2018;68(1):19–31. doi:10.1007/s12576-017-0571-7
  • Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing. 2009;6:9. doi:10.1186/1742-4933-6-9
  • Brown MA, Thom JV, Orth GL, Cova P, Juarez J. Food poisoning involving zinc contamination. Arch Environ Health. 1964;8:657–660. doi:10.1080/00039896.1964.10663736
  • Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51(2):225–227. doi:10.1093/ajcn/51.2.225
  • Murakami Y, Koyabu T, Kawashima A, et al. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon-alpha-2b and ribavirin. J Nutr Sci Vitaminol (Tokyo). 2007;53(3):213–218. doi:10.3177/jnsv.53.213
  • Raza N, Khan DA. Zinc deficiency in patients with persistent viral warts. J Coll Physicians Surg Pak. 2010;20(2):83–86.
  • Simonart T, de Maertelaer V. Systemic treatments for cutaneous warts: a systematic review. J Dermatolog Treat. 2012;23(1):72–77. doi:10.3109/09546634.2010.500324
  • Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators’ Collaborative Group. J Pediatr. 1999;135(6):689–697. doi:10.1016/s0022-3476(99)70086-7
  • Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol. 2002;71(1):16–32.
  • Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol. 2008;83(2):368–380. doi:10.1189/jlb.0307148
  • Prasad AS. Zinc: role in immunity, oxidative stress, and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(6):646–652. doi:10.1097/MCO.0b013e3283312956
  • Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5SSuppl):1399S–406S. doi:10.1093/jn/130.5.1399S
  • Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82(4):1202–1210. doi:10.1172/JCI113717
  • Sprietsma JE. Modern diets and diseases: NO-zinc balance. Under Th1, zinc, and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis, and cancer. Med Hypotheses. 1999;53(1):6–16. doi:10.1054/mehy.1999.0867
  • Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhea. Lancet. 2013;381(9875):1405–1416. doi:10.1016/S0140-6736(13)60222-6
  • Bailey RL, West KP Jr, Black RE. The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 2015;66(Suppl 2):22–33. doi:10.1159/000371618
  • Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2Suppl):447S–463S. doi:10.1093/ajcn/68.2.447S
  • DePasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr. 1984;114(10):1762–1769. doi:10.1093/jn/114.10.1762
  • Fraker PJ, Caruso R, Kierszenbaum F. Alteration of the immune and nutritional status of mice by synergy between zinc deficiency and infection with Trypanosoma cruzi. J Nutr. 1982;112(6):1224–1229. doi:10.1093/jn/112.6.1224
  • Yasuda H, Tsutsui T. Infants, and elderlies are susceptible to zinc deficiency. Sci Rep. 2016;6:21850. doi:10.1038/srep21850
  • Kluge HHP, Wickramasinghe K, Rippin HL, et al. Prevention and control of non-communicable diseases the COVID-19 response. Lancet. 2020;395(10238):1678–1680. doi:10.1016/S0140-6736(20)31067-9
  • Chabosseau P, Rutter GA. Zinc, and diabetes. Arch Biochem Biophys. 2016;611:79–85. doi:10.1016/j.abb.2016.05.022
  • Fukunaka A, Fujitani Y. Role of zinc homeostasis in the pathogenesis of diabetes and obesity. Int J Mol Sci. 2018;19(2):476. doi:10.3390/ijms19020476
  • Wang S, Gu J, Xu Z, et al. Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway. J Cell Mol Med. 2017;21(6):1182–1192. doi:10.1111/jcmm.13050
  • Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2013;6:CD001364. doi:10.1002/14651858.CD001364.pub4
  • Kumar S, Awasthi S, Jain A, Srivastava RC. Blood zinc levels in children hospitalized with severe pneumonia: a case-control study. Indian Pediatr. 2004;41(5):486–491.
  • Shakur MS, Malek MA, Bano N, Islam K. Zinc status in well-nourished Bangladeshi children suffering from acute lower respiratory infection. Indian Pediatr. 2004;41(5):478–481.
  • Ibraheem RM, Johnson AB, Abdulkarim AA, Biliaminu SA. Serum zinc levels in hospitalized children with acute lower respiratory infections in the north-central region of Nigeria. Afr Health Sci. 2014;14(1):136–142. doi:10.4314/ahs.v14i1.21
  • Eby GA. Zinc ion availability–the determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother. 1997;40(4):483–493. doi:10.1093/oxfordjournals.jac.a020864
  • Hemilä H. Common cold treatment using zinc. JAMA. 2015;314(7):730. doi:10.1001/jama.2015.8174
  • Eby GA 3rd. Zinc lozenges as cure for the common cold–a review and hypothesis. Med Hypotheses. 2010;74(3):482–492. doi:10.1016/j.mehy.2009.10.017
  • Hemilä H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J. 2011;5:51–58. doi:10.2174/1874306401105010051
  • Abd-Elsalam S, Soliman S, Esmail ES, et al. Do zinc supplements enhance the clinical efficacy of hydroxychloroquine? A randomized, multicenter trial. Biol Trace Elem Res. 2020:1–5. doi:10.1007/s12011-020-02512-1.
  • Arentz S, Hunter J, Yang G, et al. Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review. Adv Integr Med. 2020;7(4):252–260. doi:10.1016/j.aimed.2020.07.009
  • Alexander J, Tinkov A, Strand TA, Alehagen U, Skalny A, Aaseth J. Early nutritional interventions with zinc, selenium, and vitamin D for raising anti-viral resistance against progressive COVID-19. Nutrients. 2020;12(8):2358. doi:10.3390/nu12082358
  • Name JJ, Souza ACR, Vasconcelos AR, Prado PS, Pereira CPM. Zinc, vitamin D, and vitamin C: perspectives for COVID-19 with a focus on physical tissue barrier integrity. Front Nutr. 2020;7:606398. doi:10.3389/fnut.2020.606398
  • Rondanelli M, Miccono A, Lamburghini S, et al. Self-care for common colds: the pivotal role of vitamin D, vitamin C, zinc, and echinacea in three main immune interactive clusters (Physical barriers, innate and adaptive immunity) involved during an episode of common colds-practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. Evid Based Complement Alternat Med. 2018;2018:5813095. doi:10.1155/2018/5813095
  • Carlucci PM, Ahuja T, Petrilli C, Rajagopalan H, Jones S, Rahimian J. Zinc sulfate, in combination with a zinc ionophore, may improve outcomes in hospitalized COVID-19 patients. J Med Microbiol. 2020;69(10):1228–1234. doi:10.1099/jmm.0.001250
  • Agnew UM, Slesinger TL. Zinc toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 32119435.
  • Sheqwara J, Alkhatib Y. Sideroblastic anemia secondary to zinc toxicity. Blood. 2013;122(3):311. doi:10.1182/blood-2012-12-469239
  • Appenzeller-Herzog C, Mathes T, Heeres MLS, Weiss KH, Houwen RHJ, Ewald H. Comparative effectiveness of common therapies for Wilson disease: a systematic review and meta-analysis of controlled studies. Liver Int. 2019;39(11):2136–2152. doi:10.1111/liv.14179
  • Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018;56(12):1213–1415. doi:10.1080/15563650.2018.1533727
  • McPherson SW, Keunen JE, Bird AC, Chew EY, van Kuijk FJ. Investigate oral zinc as a prophylactic treatment for those at risk for COVID-19. Am J Ophthalmol. 2020;216:A5–A6. doi:10.1016/j.ajo.2020.04.028
  • Dabbagh-Bazarbachi H, Clergeaud G, Quesada IM, Ortiz M, O’Sullivan CK, Fernández-Larrea JB. Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model. J Agric Food Chem. 2014;62(32):8085–8093. doi:10.1021/jf5014633
  • Hecel A, Ostrowska M, Stokowa-Sołtys K, et al. Zinc(II)-the overlooked éminence grise of chloroquine’s fight against COVID-19? Pharmaceuticals (Basel). 2020;13(9):228. doi:10.3390/ph13090228
  • Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJ, Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol. 2009;83(1):58–64. doi:10.1128/JVI.01543-08
  • Pawar A, Pal A. Molecular and functional resemblance of dexamethasone and quercetin: a paradigm worth exploring in dexamethasone-nonresponsive COVID-19 patients. Phytother Res. 2020;34(12):3085–3088. doi:10.1002/ptr.6886
  • Brewer J, Gomez Marti JL, Brufsky A. Potential interventions for SARS-CoV-2 infections: zinc showing promise. J Med Virol. 2020. doi:10.1002/jmv.26523
  • Pal A, Pawar A, Goswami K, Sharma P, Prasad R. Hydroxychloroquine, and Covid-19: a cellular and molecular biology based update. Indian J Clin Biochem. 2020;35(3):274–284. doi:10.1007/s12291-020-00900-x
  • Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155–166. doi:10.1038/s41584-020-0372-x
  • Conway DJ. Paths to a malaria vaccine illuminated by parasite genomics. Trends Genet. 2015;31(2):97–107. doi:10.1016/j.tig.2014.12.005
  • Karunamoorthi K. Malaria vaccine: a future hope to curtail the global malaria burden. Int J Prev Med. 2014;5(5):529–538. PMID: 24932383; PMCID: PMC4050672.
  • de Beer TA, Wells GA, Burger PB, et al. Antimalarial drug discovery: in silico structural biology and rational drug design. Infect Disord Drug Targets. 2009;9(3):304–318. doi:10.2174/1871526510909030304
  • Vedadi M, Lew J, Artz J, et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol. 2007;151(1):100–110. doi:10.1016/j.molbiopara.2006.10.011
  • Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery - approaches and progress towards new medicines. Nat Rev Microbiol. 2013;11(12):849–862. doi:10.1038/nrmicro3138
  • Ridley RG. Medical need, scientific opportunity, and the drive for antimalarial drugs. Nature. 2002;415(6872):686–693. doi:10.1038/415686a
  • Mitchell W. Natural products from synthetic biology. Curr Opin Chem Biol. 2011;15(4):505–515. doi:10.1016/j.cbpa.2011.05.017
  • Paddon CJ, Westfall PJ, Pitera DJ, et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature. 2013;496(7446):528–532. doi:10.1038/nature12051
  • Buckee CO, Wesolowski A, Eagle NN, Hansen E, Snow RW. Mobile phones and malaria: modeling human and parasite travel. Travel Med Infect Dis. 2013;11(1):15–22. doi:10.1016/j.tmaid.2012.12.003
  • Hay SI, George DB, Moyes CL, Brownstein JS. Big data opportunities for global infectious disease surveillance. PLoS Med. 2013;10(4):e1001413. doi:10.1371/journal.pmed.1001413
  • Pahan P, Pahan K. Smooth or risky revisit of an old malaria drug for COVID-19? J Neuroimmune Pharmacol. 2020;15(2):174–180. doi:10.1007/s11481-020-09923-w
  • Yang ZY, Huang Y, Ganesh L, et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004;78(11):5642–5650. doi:10.1128/JVI.78.11.5642-5650.2004
  • Mehta P, McAuley DF, Brown M, et al.; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
  • Kim ML, Martin WJ, Minigo G, et al. Dysregulated IL-1β-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine. Circulation. 2018;138(23):2648–2661. doi:10.1161/CIRCULATIONAHA.118.033891
  • Batún-Garrido JAJ, Salas-Magaña M, Juárez-Rojop IE. Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis. Clin Rheumatol. 2018;37(3):631–637. doi:10.1007/s10067-017-3897-x
  • Watanabe T, Jono H, Han J, Lim DJ, Li JD. Synergistic activation of NF-kappaB by non-typeable Haemophilus influenzae and tumor necrosis factor-alpha. Proc Natl Acad Sci USA. 2004;101(10):3563–3568. doi:10.1073/pnas.0400557101
  • Saha RN, Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int. 2006;49(2):154–163. doi:10.1016/j.neuint.2006.04.007
  • Saha RN, Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal. 2006;8(5–6):929–947. doi:10.1089/ars.2006.8.929
  • Liang N, Zhong Y, Zhou J, et al. Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-κB signaling pathway in lupus nephritis mice. Exp Ther Med. 2018;15(3):2436–2442. doi:10.3892/etm.2018.5708
  • Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O. NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients. Front Immunol. 2020;11:598444. doi:10.3389/fimmu.2020.598444
  • Gasparello J, Finotti A, Gambari R. Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3ʹUTR of pro-inflammatory mRNAs. Med Hypotheses. 2020;146:110415. doi:10.1016/j.mehy.2020.110415
  • Zizzo G, Cohen PL. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19? Lancet Rheumatol. 2020;2(12):e779–e790. doi:10.1016/S2665-9913(20)30340-4
  • Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8–13. doi:10.1016/j.cyto.2018.01.025
  • Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
  • Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091
  • Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8(12):1233–1244. doi:10.1016/S2213-2600(20)30404-5
  • Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32. doi:10.1128/MMBR.05015-11
  • Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368–370. doi:10.1016/j.jmii.2020.03.005
  • De Biasi S, Meschiari M, Gibellini L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11(1):3434. doi:10.1038/s41467-020-17292-4
  • Parackova Z, Bloomfield M, Klocperk A, Sediva A. Neutrophils mediate Th17 promotion in COVID-19 patients. J Leukoc Biol. 2020. doi:10.1002/JLB.4COVCRA0820-481RRR
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
  • Zhang YY, Li BR, Ning BT. The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections. Front Immunol. 2020;11:2033. doi:10.3389/fimmu.2020.02033
  • Kjeldsen K. Hypokalemia and sudden cardiac death. Exp Clin Cardiol. 2010;15(4):e96–9.
  • Bielecka-Dabrowa A, Mikhailidis DP, Jones L, Rysz J, Aronow WS, Banach M. The meaning of hypokalemia in heart failure. Int J Cardiol. 2012;158(1):12–17. doi:10.1016/j.ijcard.2011.06.121
  • Skogestad J, Aronsen JM. Hypokalemia-induced arrhythmias and heart failure: new insights and implications for therapy. Front Physiol. 2018;9:1500. doi:10.3389/fphys.2018.01500
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. doi:10.1001/jamacardio.2020.1017
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
  • Zhang DD, Gao ZX, Vio CP, et al. Bradykinin stimulates renal Na+ and K+ excretion by inhibiting the K+ channel (Kir4.1) in the distal convoluted tubule. Hypertension. 2018;72(2):361–369. doi:10.1161/HYPERTENSIONAHA.118.11070
  • Ma L, Song K, Huang Y. Coronavirus disease-2019 (COVID-19), and cardiovascular complications. J Cardiothorac Vasc Anesth. 2020;S1053-0770(20)30400-6. doi:10.1053/j.jvca.2020.04.041
  • Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329–336. doi:10.1007/s10840-020-00789-9
  • Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177. doi:10.7554/eLife.59177
  • van de Veerdonk FL, Netea MG, van Deuren M, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555. doi:10.7554/eLife.57555
  • Offringa A, Montijn R, Singh S, Paul M, Pinto YM, Pinto-Sietsma SJ. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system. Eur Heart J Cardiovasc Pharmacother. 2020;6(5):317–325. doi:10.1093/ehjcvp/pvaa053
  • Damasceno IZ, Melo KR, Nascimento FD, et al. Bradykinin release avoids high molecular weight kininogen endocytosis. PLoS One. 2015;10(3):e0121721. doi:10.1371/journal.pone.0121721
  • Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002;109(2):195–209. doi:10.1067/mai.2002.121316
  • Kalinska M, Meyer-Hoffert U, Kantyka T, Potempa J. Kallikreins - the melting pot of activity and function. Biochimie. 2016;122:270–282. doi:10.1016/j.biochi.2015.09.023
  • Koumandou VL, Scorilas A. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One. 2013;8(7):e68074. doi:10.1371/journal.pone.0068074
  • Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin-angiotensin system in kidney physiology. Compr Physiol. 2014;4(3):1201–1228. doi:10.1002/cphy.c130040
  • Givertz MM. Manipulation of the renin-angiotensin system. Circulation. 2001;104(5):E14–8. doi:10.1161/hc3001.094733
  • Debela M, Magdolen V, Grimminger V, et al. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc-binding site. J Mol Biol. 2006;362(5):1094–1107. doi:10.1016/j.jmb.2006.08.003
  • Debela M, Goettig P, Magdolen V, Huber R, Schechter NM, Bode W. Structural basis of the zinc inhibition of human tissue kallikrein 5. J Mol Biol. 2007;373(4):1017–1031. doi:10.1016/j.jmb.2007.08.042
  • Debela M, Hess P, Magdolen V, et al. Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proc Natl Acad Sci USA. 2007;104(41):16086–16091. doi:10.1073/pnas.0707811104
  • Skala W, Utzschneider DT, Magdolen V, et al. Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity. J Biol Chem. 2014;289(49):34267–34283. doi:10.1074/jbc.M114.598201
  • Goettig P, Magdolen V, Brandstetter H. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie. 2010;92(11):1546–1567. doi:10.1016/j.biochi.2010.06.022
  • Pal A, Squitti R, Picozza M, et al. Zinc and COVID-19: basis of current clinical trials. Biol Trace Elem Res. 2020:1–11. doi:10.1007/s12011-020-02437-9.
  • Razzaque MS. COVID-19 pandemic: can boosting immune responses by maintaining adequate nutritional balance reduce viral insults? Adv Hum Biol. 2020;10(3):99–102. doi:10.4103/AIHB.AIHB_75_20
  • Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020;12(4):1181. doi:10.3390/nu12041181
  • Chaari A, Bendriss G, Zakaria D, McVeigh C. Importance of dietary changes during the coronavirus pandemic: how to upgrade your immune response. Front Public Health. 2020;8:476. doi:10.3389/fpubh.2020.00476
  • Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. doi:10.3390/nu12010236
  • Guillin OM, Vindry C, Ohlmann T, Chavatte L. Selenium, selenoproteins, and viral infection. Nutrients. 2019;11(9):2101. doi:10.3390/nu11092101
  • Taheri M, Bahrami A, Habibi P, Nouri F. A review on the serum electrolytes and trace elements role in the pathophysiology of COVID-19. Biol Trace Elem Res. 2020;1–7. doi:10.1007/s12011-020-02377-4
  • Zhang J, Taylor EW, Bennett K, Saad R, Rayman MP. Association between regional selenium status and reported outcome of COVID-19 cases in China. Am J Clin Nutr. 2020;111(6):1297–1299. doi:10.1093/ajcn/nqaa095
  • Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(5):370–374. PMID: 9342257. doi:10.1097/00042560-199708150-00007
  • Broome CS, McArdle F, Kyle JA, et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr. 2004;80(1):154–162. doi:10.1093/ajcn/80.1.154
  • Hou JC. Inhibitory effect of selenite and other antioxidants on complement-mediated tissue injury in patients with epidemic hemorrhagic fever. Biol Trace Elem Res. 1997;56(1):125–130. doi:10.1007/BF02778988
  • Bonham M, O’Connor JM, Hannigan BM, Strain JJ. The immune system as a physiological indicator of marginal copper status? Br J Nutr. 2002;87(5):393–403. PMID: 12010579. doi:10.1079/BJNBJN2002558
  • Hopkins RG, Failla ML. Copper deficiency reduces interleukin-2 (IL-2) production and IL-2 mRNA in human T-lymphocytes. J Nutr. 1997;127(2):257–262. doi:10.1093/jn/127.2.257
  • Mao S, Zhang A, Huang S. Meta-analysis of Zn, Cu, and Fe in the hair of Chinese children with recurrent respiratory tract infection. Scand J Clin Lab Invest. 2014;74(7):561–567. doi:10.3109/00365513.2014.921323
  • Vyas D, Chandra RK. Thymic factor activity, lymphocyte stimulation response, and antibody-producing cells in copper deficiency. Nutr Res. 1983;3(3):343–349. doi:10.1016/S0271-5317(83)80084-0
  • Calder PC. Nutrition, immunity, and COVID-19. BMJ Nutr Prev Health. 2020;3(1):74–92. doi:10.1136/bmjnph-2020-000085
  • Iddir M, Brito A, Dingeo G, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562. doi:10.3390/nu12061562
  • Liu W, Zhang S, Nekhai S, Liu S. Depriving iron supply to the virus represents a promising adjuvant therapeutic against viral survival. Curr Clin Microbiol Rep. 2020;1–7. doi:10.1007/s40588-020-00140-w
  • Fernández-Quintela A, Milton-Laskibar I, Trepiana J, et al. Key aspects in nutritional management of COVID-19 patients. J Clin Med. 2020;9(8):2589. doi:10.3390/jcm9082589
  • Joseph N, Nelliyanil M, Rai S, et al. Fast-food consumption pattern and its association with overweight among high school boys in Mangalore City of Southern India. J Clin Diagn Res. 2015;9(5):LC13–LC17. doi:10.7860/JCDR/2015/13103.5969
  • Abiri B, Vafa M. Micronutrients that affect immunosenescence. Adv Exp Med Biol. 2020;1260:13–31. doi:10.1007/978-3-030-42667-5_2
  • Pae M, Wu D. Nutritional modulation of age-related changes in the immune system and risk of infection. Nutr Res. 2017;41:14–35. doi:10.1016/j.nutres.2017.02.001
  • Maggini S, Pierre A, Calder PC. Immune function and micronutrient requirements change over the life course. Nutrients. 2018;10(10):1531. doi:10.3390/nu10101531
  • Di Renzo L, Gualtieri P, Pivari F, et al. COVID-19: is there a role for immunonutrition in obese patient? J Transl Med. 2020;18(1):415. doi:10.1186/s12967-020-02594-4
  • Darnton-Hill I. Public health aspects in the prevention and control of vitamin deficiencies. Curr Dev Nutr. 2019;3(9):nzz075. doi:10.1093/cdn/nzz075
  • Fantacone ML, Lowry MB, Uesugi SL, et al. The effect of a multivitamin and mineral supplement on immune function in healthy older adults: a double-blind, randomized, controlled trial. Nutrients. 2020;12(8):2447. doi:10.3390/nu12082447
  • Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: the inflammation link and the role of nutrition in potential mitigation. Nutrients. 2020;12(5):1466. doi:10.3390/nu12051466
  • Galmés S, Serra F, Palou A. Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients. 2020;12(9):2738. doi:10.3390/nu12092738
  • Junaid K, Ejaz H, Abdalla AE, et al. Effective immune functions of micronutrients against SARS-CoV-2. Nutrients. 2020;12(10):2992. doi:10.3390/nu12102992
  • Dalan R, Bornstein SR, El-Armouche A, et al. The ACE-2 in COVID-19: foe or friend? Horm Metab Res. 2020;52(5):257–263. doi:10.1055/a-1155-0501
  • Rahman MT, Idid SZ. Can Zn be a critical element in COVID-19 treatment? Biol Trace Elem Res. 2020;1–9. doi:10.1007/s12011-020-02194-9
  • Muzzioli M, Stecconi R, Donnini A, Re F, Provinciali M. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor. Int J Biochem Cell Biol. 2007;39(5):955–965. doi:10.1016/j.biocel.2007.01.011
  • Prager I, Liesche C, van Ooijen H, et al. NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J Exp Med. 2019;216(9):2113–2127. doi:10.1084/jem.20181454
  • Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 2014;7(5):545–594. doi:10.3390/ph7050545
  • Negishi H, Taniguchi T, Yanai H. The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family. Cold Spring Harb Perspect Biol. 2018;10(11):a028423. doi:10.1101/cshperspect.a028423
  • World Bank. Global economic prospects, June 2020. Washington, DC: World Bank. © World Bank. License: CC BY 3.0 IGO; 2020. Available from: https://openknowledge.worldbank.org/handle/10986/33748. Accessed November 26, 2020.
  • Centers for Disease Control and Prevention. Principles of epidemiology in public health practice, third edition an introduction to applied epidemiology and biostatistics; 2011. Available from: https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section11.html. Accessed November 26, 2020.
  • Institute of Medicine (US) Forum on Microbial Threats. Ethical and legal considerations in mitigating pandemic disease: workshop summary. Washington (DC): National Academies Press (US); 2007. 3: Strategies for Disease Containment. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54163/. Accessed November 27, 2020.
  • Madhav N, Oppenheim B, Gallivan M, et al. Pandemics: risks, impacts, and mitigation. In: Jamison DT, Gelband H, Horton S, et al. editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; November 27, 2017. Chapter 17. doi:10.1596/978-1-4648-0527-1_ch17
  • World O Meter. COVID-19 coronavirus pandemic. Coronavirus; 2020. Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?%22. Accessed January 19, 2021.
  • The World Bank. COVID-19 to plunge global economy into worst recession since World War II; 2020. Available from: https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii. Accessed November 28, 2020.
  • Zumbrun J World bank sees 5.2% decline in global economy in 2020 from coronavirus. The Wall Street Journal; 2020. Available from: https://www.wsj.com/articles/world-bank-sees-5-2-decline-in-global-economy-in-2020-from-coronavirus-11591631209. Accessed November 28, 2020.
  • The Lancet. India under COVID-19 lockdown. Lancet. 2020;395(10233):1315. doi:10.1016/S0140-6736(20)30938-7.
  • Sjödin H, Wilder-Smith A, Osman S, Farooq Z, Rocklöv J. Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. Euro Surveill. 2020;25(13):2000280. doi:10.2807/1560-7917.ES.2020.25.13.2000280
  • Garcia LP, Duarte E. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil. Epidemiol Serv Saude. 2020;29(2):e2020222. doi:10.5123/S1679-49742020000200009
  • Burkert A, Loeb A Flattening the COVID-19 curves. Scientific American. Observations, opinion; 2020. Available from: https://blogs.scientificamerican.com/observations/flattening-the-covid-19-curves/. Accessed November 28, 2020.
  • Khoo EJ, Lantos JD. Lessons learned from the COVID-19 pandemic. Acta Paediatr. 2020;109(7):1323–1325. doi:10.1111/apa.15307
  • Buck T, Arnold M, Chazan G, Cookson C Coronavirus declared a pandemic as fears of economic crisis mount. Financial Times; 2020. Available from: https://www.ft.com/content/d72f1e54-6396-11ea-b3f3-fe4680ea68b5. Accessed November 28, 2020.
  • The World Bank. Economic and social impacts of COVID-19: updates from the listening to Tajikistan survey; 2020. Available from: https://www.worldbank.org/en/news/factsheet/2020/07/13/economic-and-social-impacts-of-covid-19-update-from-listening-to-tajikistan. Accessed November 28, 2020.
  • Lim LL The socioeconomic impacts of COVID-19 in Malaysia: policy review and guidance for protecting the most vulnerable and supporting enterprises. International Laboure Organization; 2020. Available from: http://ilo.org/wcmsp5/groups/public/---asia/---ro-bangkok/documents/publication/wcms_751600.pdf. Accessed November 28, 2020.
  • Ghebreyesus TA. Strengthening our resolve for primary health care. Bull World Health Organ. 2020;98(11):726–726A. doi:10.2471/BLT.20.279489
  • White F. Primary health care and public health: foundations of universal health systems. Med Princ Pract. 2015;24(2):103–116. doi:10.1159/000370197
  • Rao M, Pilot E. The missing link–the role of primary care in global health. Glob Health Action. 2014;7:23693. doi:10.3402/gha.v7.23693
  • Druetz T. Integrated primary health care in low- and middle-income countries: a double challenge. BMC Med Ethics. 2018;19(Suppl 1):48. doi:10.1186/s12910-018-0288-z
  • Global spending on health: a world in transition. Geneva: World Health Organization; 2019. Available from: https://apps.who.int/iris/rest/bitstreams/1264564/retrieve. Accessed November 28, 2020.
  • World Health Organization and the United Nations Children’s Fund (UNICEF). A vision for primary health care in the 21st century: towards universal health coverage and the sustainable development goals. Geneva; 2018. (WHO/HIS/SDS/2018.X). License: CC BY-NC-SA 3.0.IGO. Available from: https://www.who.int/docs/default-source/primary-health/vision.pdf. Accessed November 28, 2020.
  • World Health Organization. Primary health care; 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/primary-health-care. Accessed November 28, 2020.
  • Langlois EV, McKenzie A, Schneider H, Mecaskey JW. Measures to strengthen primary healthcare systems in low- and middle-income countries. Bull World Health Organ. 2020;98(11):781–791. doi:10.2471/BLT.20.252742
  • Lim WH, Wong WM. COVID-19: notes from the front line, Singapore’s primary health care perspective. Ann Fam Med. 2020;18(3):259–261. doi:10.1370/afm.2539
  • Sarti TD, Lazarini WS, Fontenelle LF. Organization of Primary Health Care in pandemics: a rapid systematic review of the literature in times of COVID-19. medRxiv. 2020. doi:10.1101/2020.07.05.20146811
  • Bitton A, Fifield J, Ratcliffe H, et al. Primary healthcare system performance in low-income and middle-income countries: a scoping review of the evidence from 2010 to 2017. BMJ Glob Health. 2019;4(Suppl 8):e001551. doi:10.1136/bmjgh-2019-001551
  • Stenberg K, Hanssen O, Bertram M, et al. Guideposts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modeling study. Lancet Glob Health. 2019;7(11):e1500–e1510. doi:10.1016/S2214-109X(19)30416-4
  • Fadlallah R, Bou-Karroum L, El-Jardali F, et al. Quality, safety and performance management in primary health care: from scoping review to research priority setting and implementation plan in the Eastern Mediterranean Region. BMJ Glob Health. 2019;4(Suppl 8):e001477. doi:10.1136/bmjgh-2019-001477
  • Perry HB, Rassekh BM, Gupta S, Freeman PA. Comprehensive review of the evidence regarding the effectiveness of community-based primary health care in improving maternal, neonatal, and child health: 7. shared characteristics of projects with evidence of long-term mortality impact. J Glob Health. 2017;7(1):010907. doi:10.7189/jogh.07.010907
  • Perry HB, Rassekh BM, Gupta S, Wilhelm J, Freeman PA. Comprehensive review of the evidence regarding the effectiveness of community-based primary health care in improving maternal, neonatal, and child health: 1. rationale, methods, and database description. J Glob Health. 2017;7(1):010901. doi:10.7189/jogh.07.010901
  • Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health. 2018;6(11):e1196–e1252. doi:10.1016/S2214-109X(18)30386-3
  • Chang BB, Chiu TY. Ready for a long fight against the COVID-19 outbreak: an innovative model of tiered primary health care in Taiwan. BJGP Open. 2020;4(2):bjgpopen20X101068. doi:10.3399/bjgpopen20X101068
  • Jan CF, Chiu TY, Chen CY, Guo FR, Lee MC. A 10-year review of health care reform on family practice integrated care project-Taiwan experience. Fam Pract. 2018;35(4):352–357. doi:10.1093/fampra/cmx111
  • Chang CM, Tan TW, Ho TC, Chen CC, Su TH, Lin CY. COVID-19: taiwan’s epidemiological characteristics and public and hospital responses. Peer J. 2020;8:e9360. doi:10.7717/peerj.9360
  • Summers J, Cheng H-Y, Lin -H-H, et al. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pacific. 2020. doi:10.1016/j.lanwpc.2020.100044
  • Rawaf S, Allen LN, Stigler FL, et al. Lessons on the COVID-19 pandemic, for and by primary care professionals worldwide. Eur J Gen Pract. 2020;26(1):129–133. doi:10.1080/13814788.2020.1820479
  • Palaniappan A, Dave U, Gosine B. Comparing South Korea and Italy’s healthcare systems and initiatives to combat COVID-19. Rev Panam Salud Publica. 2020;44:e53. doi:10.26633/RPSP.2020.53
  • Oh J, Lee JK, Schwarz D, Ratcliffe HL, Markuns JF, Hirschhorn LR. National response to COVID-19 in the Republic of Korea and lessons learned for other countries. Health Syst Reform. 2020;6(1):e1753464. doi:10.1080/23288604.2020.1753464
  • Tan Z, Khoo DWS, Zeng LA, et al. Protecting health care workers in the front line: innovation in COVID-19 pandemic. J Glob Health. 2020;10(1):010357. doi:10.7189/jogh.10.010357
  • Gai R, Tobe M. Managing healthcare delivery system to fight the COVID-19 epidemic: experience in Japan. Glob Health Res Policy. 2020;5:23. doi:10.1186/s41256-020-00149-0
  • Tashiro A, Shaw R. COVID-19 pandemic response in Japan: what is behind the initial flattening of the curve? Sustainability. 2020;12:5250. doi:10.3390/su12135250
  • Chen KT, Twu SJ, Chang HL, et al. SARS in Taiwan: an overview and lessons learned. Int J Infect Dis. 2005;9(2):77–85. doi:10.1016/j.ijid.2004.04.015
  • Hsieh YH, King CC, Chen CW, et al. Quarantine for SARS, Taiwan. Emerg Infect Dis. 2005;11(2):278–282. doi:10.3201/eid1102.040190
  • Lin C, Braund WE, Auerbach J, et al. Policy decisions and use of information technology to fight COVID-19, Taiwan. Emerg Infect Dis. 2020;26(7):1506–1512. doi:10.3201/eid2607.200574
  • Su YF, Wu CH, Lee TF. Public health emergency response in Taiwan. Health Secur. 2017;15(2):137–143. doi:10.1089/hs.2016.0108
  • Samad N, Sodunke TE, Banna HA, et al. Convalescent plasma therapy for management of COVID-19: perspectives and deployment in the current global pandemic. Risk Manag Healthc Policy. 2020;13:2707–2728. doi:10.2147/RMHP.S281388
  • Barron L What we can learn from Singapore, Taiwan, and Hong Kong about handling coronavirus. The Time; 2020. Available from: https://time.com/5802293/coronavirus-covid19-singapore-hong-kong-taiwan/. Accessed November 28, 2020.
  • Sakamoto H, Rahman M, Nomura S, et al. Japan Health System Review. Vol. 8 No. 1. New Delhi: World Health Organization, Regional Office for Southeast Asia; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259941/9789290226260-eng.pdf;jsessionid=315E87830F83DC354350E24117FF59B5?sequence=1. Accessed November 29, 2020.
  • Ikegami N, Yoo BK, Hashimoto H, et al. Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378(9796):1106–1115. doi:10.1016/S0140-6736(11)60828-3
  • Ikegami N. Japanese health care: low cost through regulated fees. Health Aff (Millwood). 1991;10(3):87–109. doi:10.1377/hlthaff.10.3.87
  • Edmond C Elderly people make up a third of Japan’s population – and it’s reshaping the country. World Economic Forum; 2019. Available from: https://www.weforum.org/agenda/2019/09/elderly-oldest-population-world-japan/#:~:text=Japan%20has%20the%20highest%20old,ages%20of%2020%20and%2064. Accessed November 28, 2020.
  • Sakamoto H, Kita Y, Ezoe S How Japan’s universal health care system led to COVID-19 Success. Tokyo report, the diplomat. 2020. Available from: https://thediplomat.com/2020/08/how-japans-universal-health-care-system-led-to-covid-19-success/. Accessed November 28, 2020.
  • Hamaguchi R, Negishi K, Higuchi M, Funato M, Kim J-H, Bitton A A regionalized public health model to combat COVID-19: lessons from Japan. Global health policy. Health affairs; 2020. Available from: https://www.healthaffairs.org/do/10.1377/hblog20200721.404992/full/. Accessed November 28, 2020.
  • Japan renews primary health care to promote healthy aging. Bull World Health Organ. 2018;96(7):448–449. doi:10.2471/BLT.18.030718
  • Kato D, Ryu H, Matsumoto T, et al. Building primary care in Japan: literature review. J Gen Fam Med. 2019;20(5):170–179. doi:10.1002/jgf2.252
  • Oliver L Coronavirus: a pandemic in the age of inequality. World Economic Forum; 2019. Available from: https://www.weforum.org/agenda/2020/03/coronavirus-pandemic-inequality-among-workers/. Accessed November 28, 2020.
  • Pringle D, Levitt C, Horsburgh ME, Wilson R, Whittaker MK. Interdisciplinary collaboration and primary health care reform. Can J Public Health. 2000;91(2):85–8, 97. doi:10.1007/BF03404916
  • Morley L, Cashell A. Collaboration in health care. J Med Imaging Radiat Sci. 2017;48(2):207–216. doi:10.1016/j.jmir.2017.02.071
  • Jaruseviciene L, Liseckiene I, Valius L, Kontrimiene A, Jarusevicius G, Lapão LV. Teamwork in primary care: perspectives of general practitioners and community nurses in Lithuania. BMC Fam Pract. 2013;14:118. doi:10.1186/1471-2296-14-118
  • Chapa OR, Fuller SM, Hernandez LJ, McCray T. Competition versus collaboration in health care teams. Creat Nurs. 2017;23(2):97–101. doi:10.1891/1078-4535.23.2.97
  • Razzaque MS. Implementation of antimicrobial stewardship to reduce antimicrobial drug resistance. Expert Rev Anti Infect Ther. 2020;1–4. doi:10.1080/14787210.2021.1840977
  • Pereno A, Eriksson D. A multi-stakeholder perspective on sustainable healthcare: from 2030 onwards. Futures. 2020;122:102605. doi:10.1016/j.futures.2020.102605
  • World Health Organization. Multisectoral and intersectoral action for improved health and well-being for all: mapping of the WHO European Region. Governance for a sustainable future: improving health and well-being for all. Final Report. WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark; 2018. Available from: https://www.euro.who.int/__data/assets/pdf_file/0005/371435/multisectoral-report-h1720-eng.pdf. Accessed November 28, 2020.
  • Browne AJ, Varcoe CM, Wong ST, et al. Closing the health equity gap: evidence-based strategies for primary health care organizations. Int J Equity Health. 2012;11:59. doi:10.1186/1475-9276-11-59
  • Thomas SL, Wakerman J, Humphreys JS. Ensuring equity of access to primary health care in rural and remote Australia - what core services should be locally available? Int J Equity Health. 2015;14:111. doi:10.1186/s12939-015-0228-1
  • Wakerman J, Sparrow L, Thomas SL, Humphreys JS, Jones M. Equitable resourcing of primary health care in remote communities in Australia’s Northern Territory: a pilot study. BMC Fam Pract. 2017;18(1):75. doi:10.1186/s12875-017-0646-9
  • McGrail MR, Humphreys JS. Spatial access disparities to primary health care in rural and remote Australia. Geospat Health. 2015;10(2):358. doi:10.4081/gh.2015.358
  • Haque M, Islam T, Rahman NAA, et al. Strengthening primary health-care services to help prevent and control long-term (Chronic) non-communicable diseases in low- and middle-income countries. Risk Manag Healthc Policy. 2020;13:409–426. doi:10.2147/RMHP.S239074
  • Watkins DA, Jamison DT, Mills T, et al. Universal health coverage and essential packages of care. In: Jamison DT, Gelband H, Horton S, et al. editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; November 27, 2017. doi:10.1596/978-1-4648-0527-1_ch3

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.